Board of Directors

Elected annually by our shareholders, the Board of Directors is the company's ultimate decision-making body. The directors select and monitor the performance of our senior executives on Bristol-Myers Squibb's Leadership Team, who are responsible for the day-to-day operation of the company. Directors also act as advisors and counselors to our senior management.

Giovanni Caforio

Giovanni Caforio, M.D.

Chairman of the Board and Chief Executive Officer, Bristol-Myers Squibb 

Triangle Icon
Peter J. Arduini

Peter J. Arduini

President and Chief Executive Officer of Integra LifeSciences Holdings Corporation

Triangle Icon
José Baselga, M.D., Ph.D.

José Baselga, M.D., Ph.D.

Physician-in-Chief of Memorial Sloan-Kettering Cancer Center and Professor of Medicine at Weill Cornell Medical College

Triangle Icon
Robert J. Bertolini

Robert J. Bertolini

Former President and Chief Financial Officer of Bausch & Lomb Incorporated

Triangle Icon
 Matthew W. Emmens

Matthew W. Emmens

Retired Chief Executive Officer and Chairman of the Board of Shire PLC

Triangle Icon
Michael Grobstein

Michael Grobstein

Retired Vice Chairman of Ernst & Young LLP

Triangle Icon
Alan J. Lacy

Alan J. Lacy

Former Non-Executive Chairman, Dave & Buster's Entertainment, Inc.

Triangle Icon
Dinesh C. Paliwal

Dinesh C. Paliwal

President and Chief Executive Officer, Harman International

Triangle Icon
Theodore R. Samuels

Theodore R. Samuels

Retired President of Capital Guardian Trust Company

Triangle Icon
Vicki L. Sato

Vicki L. Sato, Ph.D.

Chairman of the Board of Denali Therapeutics, Inc. and Lead Independent Director, Bristol-Myers Squibb

Triangle Icon
Gerald L. Storch

Gerald L. Storch

Chief Executive Officer, Storch Advisors

Triangle Icon
Karen H. Vousden, Ph.D.

Karen H. Vousden, Ph.D.

Senior Group Leader, The Francis Crick Institute and Chief Scientist, Cancer Research UK

Triangle Icon